C3 thanks Representative Rosa DeLauro

Posted by Nancy Roach on April 7th, 2006

Representative Rosa DeLauro, a survivor of ovarian cancer, raised critical questions at the House Labor, Health and Human Services committee meeting around a critical translational research program.

During her questions, Rep. DeLauro identified the critical role of organ site-specific translational research which is occurring in NCI’s Specialized Program of Research Excellence (SPORE) programs. The SPORE programs offer a unique opportunity for “team science” that includes basic scientists with clinical researchers, and moves treatments from the laboratory to people.

C3 thanks Representative DeLauro for her leadership!

Comments (0): Add a comment

Leave a Reply

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. FightCRC is not responsible for the medical accuracy of any comments left by persons other than FightCRC staff members. FightCRC staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites.